Chickasaw Capital Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-8,928
Closed -$689K 106
2018
Q3
$689K Hold
8,928
0.01% 73
2018
Q2
$604K Hold
8,928
0.01% 78
2018
Q1
$647K Hold
8,928
0.02% 76
2017
Q4
$672K Hold
8,928
0.01% 75
2017
Q3
$687K Hold
8,928
0.01% 71
2017
Q2
$668K Hold
8,928
0.01% 72
2017
Q1
$594K Hold
8,928
0.01% 71
2016
Q4
$583K Hold
8,928
0.01% 67
2016
Q3
$632K Hold
8,928
0.01% 60
2016
Q2
$660K Hold
8,928
0.02% 60
2016
Q1
$580K Hold
8,928
0.02% 63
2015
Q4
$688K Hold
8,928
0.02% 67
2015
Q3
$735K Hold
8,928
0.03% 65
2015
Q2
$787K Hold
8,928
0.02% 71
2015
Q1
$789K Hold
8,928
0.02% 70
2014
Q4
$741K Hold
8,928
0.03% 73
2014
Q3
$753K Hold
8,928
0.03% 71
2014
Q2
$724K Sell
8,928
-3,675
-29% -$289K 0.03% 70
2014
Q1
$960K Buy
12,603
+327
+3% +$23.8K 0.05% 66
2013
Q4
$884K Hold
12,276
0.05% 72
2013
Q3
$844K Hold
12,276
0.06% 69
2013
Q2
$778K Buy
+12,276
New +$799K 0.06% 70

Other funds holding NVS

Chickasaw Capital Management's NVS Position: Q4 2018 in Review

Chickasaw Capital Management sold out of Novartis (NVS) in Q4 2018, closing a stake of 8,928 shares — an estimated $689K sold.

Chickasaw Capital Management first reported a position in NVS in Q2 2013 and held it in 22 quarters. The position peaked at $960K in Q1 2014. 1,087 funds tracked by Wall St. Rank hold NVS as of Q4 2018.

  • Chickasaw Capital Management reported no remaining Novartis position as of Q4 2018 after selling out during the quarter.
  • Chickasaw Capital Management sold 8,928 Novartis shares in Q4 2018, an estimated $689K.
  • Chickasaw Capital Management first reported a position in Novartis in Q2 2013 and held it in 22 quarters.
  • Chickasaw Capital Management's Novartis position peaked at $960K in Q1 2014.
  • 1,087 funds tracked by Wall St. Rank held Novartis as of Q4 2018.

Based on Chickasaw Capital Management's 13F filing for Q4 2018, filed 11 Jan 2019.